Brazilian Company Gets Warning for Lack Of Stability Data, Faulty Testing

Drug GMP Report
Lima & Pergher Industria failed to provide stability data to ensure its drug products’ expiration dates and did not perform microbiological testing on each finished product, the FDA said in a warning letter to the Brazilian company.

To View This Article:


Subscribe To Drug GMP Report